The common marmoset as a novel preclinical transplant model: Identification of new MHC class II DRB alleles and prediction of in vitro alloreactivity

Tissue Antigens

Volumn 69, Issue SUPPL. 1, 2007, Pages 72-75

  Prasad, S ^a,b   Humphreys, I ^c   Kireta, S ^a   Gilchrist, R B ^b   Bardy, P ^c   Russ, G R ^a,b   Coates, P T H ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

Alloreactivity; Common marmoset; Major histocompatibility complex; Mixed lymphocyte reaction; Non human primate; Sequence based typing; Transplantation

Indexed keywords

GENOMIC DNA; HLA DR ANTIGEN; HLA DRB2 ANTIGEN; THYMIDINE; UNCLASSIFIED DRUG;

ALLELE; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD SAMPLING; CELL CULTURE; CELL PROLIFERATION; COMPUTER PROGRAM; CONFERENCE PAPER; CONTROLLED STUDY; DENSITY GRADIENT; DNA EXTRACTION; EXON; GENE AMPLIFICATION; GENETIC IDENTIFICATION; GENOTYPE; HLA TYPING; IN VITRO STUDY; INHERITANCE; LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MARMOSET; NONHUMAN; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIBLING; SPLEEN; T LYMPHOCYTE;

ALLELES; ANIMALS; CALLITHRIX; DISEASE MODELS, ANIMAL; GENE FREQUENCY; GENOTYPE; HLA-DR ANTIGENS; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA; CALLITHRIX JACCHUS; MACACA MULATTA; MARMOSETS; PAPIO; PRIMATES;

EID: 34247199615     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.760_7.x     Document Type: Conference Paper

References (10)

1. 't Hart BA, van Meurs M, Brok HPM et al. A new primate model for multiple sclerosis in the common marmoset. Immunol Today 2000: 21: 290-7.
2. Gilchrist RB, Wicherek M, Heistermann M, Nayudu PL, Hodges JK. Changes in follicle-stimulating hormone and follicle populations during the ovarian cycle of the common marmoset. Biol Reprod 2001: 64: 127-35.
3. Soars MG, Riley RJ, Burchell B. Evaluation of the marmoset as a model species for drug glucuronidation. Xenobiotica 2001: 31: 849-60.
4. Kireta S, Zola H, Gilchrist RB, Coates PT. Cross-reactivity of anti-human chemokine receptor and anti-TNF family antibodies with common marmoset (Callithrix jacchus) leukocytes. Cell Immunol 2005: 236: 115-22.
5. Hibino H, Tani K, Ikebuchi K et al. The common marmoset as a target preclinical primate model for cytokine and gene therapy studies. Blood 1999: 93: 2839-48.
6. Bontrop RE, Otting N, De Groot N, Doxiadis GGM. Major histocompatibility complex class II polymorphisms in primates (genomic organisation of the MHC: structure, origin and function). Immunol Rev 1999: 167: 339-50.
7. Antunes SG, de Groot NG, Brok H et al. The common marmoset: a new world primate species with limited Mhc class II variability. Proc Natl Acad Sci USA 1998: 95: 11745-50.
8. Trtkova K, Kupfermann H, Grahovac B et al. Mhc-DRB genes of platyrrhine primates. Immunogenetics 1993: 38: 210-22.
9. Wu MS, Tani K, Sugiyama H et al. MHC (major histocompatibility complex)-DRB genes and polymorphisms in common marmoset. J Mol Evol 2000: 51: 214-22.
10. Robinson J, Waller MJ, Parham P et al. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 2003: 31: 311-4.